EUCTR2017-003726-32-IT进行中（未招募）1 期
Two-year effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity - NN9536-4378
OVO NORDISK. S.P.A.0 个研究点目标入组 300 人开始时间: 2021年6月15日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male or female, age 18 years or older at the time of signing informed consent
- •2. Body mass index (BMI) equal to or above 30 kg/sqm or equal to or above 27 kg/sqm with the presence of at least one of the following weight-related comorbidities (treated or untreated): hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease
- •3. History of at least one self-reported unsuccessful dietary effort to lose body weight
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 270
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •1. HbA1c equal to or above 48 mmol/mol (6.5%) as measured by the central laboratory at screening
- •2. A self-reported change in body weight above 5 kg (11 lbs) within 90 days before screening irrespective of medical records
研究者
相似试验
进行中（未招募）
1 期
STEP 5: Two-year research study investigating how well semaglutide works in people suffering from overweight or obesityObesityOverweightMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10033307Term: OverweightSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-003726-32-HUovo Nordisk A/S300
进行中（未招募）
1 期
STEP 5: Two-year research study investigating how well semaglutide works in people suffering from overweight or obesityObesityOverweightMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10033307Term: OverweightSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-003726-32-ESovo Nordisk A/S304
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people suffering from overweight or obesityMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersObesityEUCTR2017-003473-34-NLovo Nordisk A/S900
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people suffering from overweight or obesityObesityEUCTR2017-003473-34-PTovo Nordisk A/S902
进行中（未招募）
1 期
Research study investigating how well semaglutide works in people suffering from overweight or obesityObesityEUCTR2017-003436-36-PLovo Nordisk A/S1,950